COVID-19 Research Paper Volume 13, Issue 2 pp 1591—1607

Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases

The dynamic changes over 5 consecutive days in inflammatory markers in critical type COVID-19 patients with or without anticoagulation treatment. (A, B) CRP; (C, D) IL-6; (E, F) PCT (G, H) Lymphocyte; (I, J) Eosinophil. All P values can be found in Supplementary Table 2. COVID-19: coronavirus disease 2019, NAC: non-anticoagulant; AC: anticoagulant, CRP: c-reactive protein, IL-6: Interleukin-6, PCT: procalcitonin.

Figure 4. The dynamic changes over 5 consecutive days in inflammatory markers in critical type COVID-19 patients with or without anticoagulation treatment. (A, B) CRP; (C, D) IL-6; (E, F) PCT (G, H) Lymphocyte; (I, J) Eosinophil. All P values can be found in Supplementary Table 2. COVID-19: coronavirus disease 2019, NAC: non-anticoagulant; AC: anticoagulant, CRP: c-reactive protein, IL-6: Interleukin-6, PCT: procalcitonin.